Your browser doesn't support javascript.
loading
Reply to 'Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab"'.
López Sanz, Pablo; Guzmán Pérez, Marta; Guerrero Ramírez, Claudia; Manso Córdoba, Silvia; Alfaro Martínez, María Encarnación; Azaña Defez, José Manuel.
Afiliação
  • López Sanz P; Departments of Dermatology.
  • Guzmán Pérez M; Internal Medicine, University General Hospital of Albacete, Albacete, Spain.
  • Guerrero Ramírez C; Departments of Dermatology and Internal Medicine, University General Hospital of Albacete, Albacete, Spain.
  • Manso Córdoba S; Departments of Dermatology.
  • Alfaro Martínez ME; Departments of Dermatology and Internal Medicine, University General Hospital of Albacete, Albacete, Spain.
  • Azaña Defez JM; Departments of Dermatology.
Clin Exp Dermatol ; 48(8): 940-941, 2023 07 21.
Article em En | MEDLINE | ID: mdl-37098182
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Hidradenite Supurativa / Deficiência de Mevalonato Quinase / Medicamentos Biossimilares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Hidradenite Supurativa / Deficiência de Mevalonato Quinase / Medicamentos Biossimilares Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article